Authors: Nordoy, T Kolstad, A Tuck, MK Aaberge, IS Husebekk, A Kaminski, MS

Citation: T. Nordoy et al., Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens, CLIN IMMUNO, 100(1), 2001, pp. 40-48

Authors: Nordoy, T Husebekk, A Aaberge, IS Jenum, PA Samdal, HH Flugsrud, LB Kristoffersen, AC Holte, H Kvaloy, S Kolstad, A

Citation: T. Nordoy et al., Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines, BONE MAR TR, 28(7), 2001, pp. 681-687

Authors: Knobel, H Loge, JH Nordoy, T Kolstad, AL Espevik, T Kvaloy, S Kaasa, S

Citation: H. Knobel et al., High level of fatigue in lymphoma patients treated with high dose therapy, J PAIN SYMP, 19(6), 2000, pp. 446-456

Authors: Nordoy, T Kolstad, A Husebekk, A

Citation: T. Nordoy et al., Persistent immunological changes 55 months after PBPCT. Is the restorationof immune function possible with a longer follow-up? Response, BONE MAR TR, 26(6), 2000, pp. 708-708

Authors: Nordoy, T Kolstad, A Endresen, P Holte, H Kvaloy, S Kvalheim, G Husebekk, A

Citation: T. Nordoy et al., Persistent changes in the immune system 4-10 years after ABMT, BONE MAR TR, 24(8), 1999, pp. 873-878